Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 4, 2015
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptanRamón De Las Peñas, Santiago Ponce, Fernando Henao, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2024
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancerMaria Saigí, Jose L Mate, Enric Carcereny, et al.
Cancer Investigation|March 29, 2017
Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07Nuria Viñolas, Pilar Garrido, Dolores Isla, et al.
European Journal of Cancer Care|October 3, 2018
Lung cancer in Spanish women: The WORLD07 projectPilar Garrido, Nuria Viñolas, Dolores Isla, et al.
Gaceta Sanitaria|May 31, 2022
[Representativeness of the Spanish Thoracic Tumour Registry. Comparison of sociodemographic data with other national registries]Cristina Candal-Pedreira, Alberto Ruano-Ravina, Enric Carcereny, et al.
Translational Lung Cancer Research|March 26, 2015
ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutationNiki Karachaliou, Ana Gimenez-Capitan, Ana Drozdowskyj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2008
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphismsAlbert Font, Ramon Salazar, Joan Maurel, et al.
Exploration of Targeted Anti-Tumor Therapy|January 12, 2024
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu, et al.
Oncology Research and Treatment|February 26, 2019
A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung CancerTeresa Moran, Vanesa Quiroga, Beatriz Cirauqui, et al.
Pageof 11